Skip to content

Patient-Initiated and ConTrolled Oral Refeeding (PICTOR)

A Randomized Controlled Trial of Patient-Initiated and ConTrolled Oral Refeeding in Acute Pancreatitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01728896
Acronym
PICTOR
Enrollment
56
Registered
2012-11-20
Start date
2013-12-01
Completion date
2019-06-01
Last updated
2019-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Keywords

Acute pancreatitis, nutrition

Brief summary

The first step in treating patients with acute pancreatitis is to provide pain relief and intravenous fluids to keep them comfortable. As the pain subsides and patient starts to feel better food and fluids by mouth are restarted. This is done to rest the pancreas which is the organ that has been inflamed. In some patients when food by mouth restarts they have pain and as a consequence they have a longer stay in hospital. It is thought that patients who have little pain and are within 24 hours of admission to hospital do well if they control their own food intake. This is in contrast to the usual treatment where the treating team advise when eating should restart.

Interventions

OTHERPatient-controlled oral refeeding

Sponsors

University of Auckland, New Zealand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of acute pancreatitis * age \> 18 years * written informed consent

Exclusion criteria

* ongoing need for opiates * \>96 hours after onset of symptoms * chronic pancreatitis * post-ERCP pancreatitis * intraoperative diagnosis * pregnancy * malignancy * received nutrition before randomisation

Design outcomes

Primary

MeasureTime frame
Oral food intoleranceParticipants will be followed for the duration of hospital stay, an expected average of 7 days

Secondary

MeasureTime frameDescription
Time from admission until tolerance of oral foodParticipants will be followed for the duration of hospital stay, an expected average of 7 days
Total length of hospital stayParticipants will be followed for the duration of hospital stay, an expected average of 7 days
Need for opiatesParticipants will be followed for the duration of hospital stay, an expected average of 7 daysNeed for opiates is defined when one (or more) of the following has been administered: * Codeine phosphate * Fentanyl * Morphine, Sevredol, Meslon * Oxynorm, Oxycodone * Tramadol
Progression of acute pancreatitis severityParticipants will be followed for the duration of hospital stay, an expected average of 7 daysTo be defined according to the 2012 determinant-based classification of acute pancreatitis severity
Hospital readmission2 weeks after hospital discharge
Change in pain intensityBaseline and 24, 48, 72h after randomisation
Number and type of interventions during hospital stayParticipants will be followed for the duration of hospital stay, an expected average of 7 days
Time from admission until first flatusParticipants will be followed for the duration of hospital stay, an expected average of 7 days
Change in blood glucoseBaseline and 24, 48, 72h after randomisation
Change in plasma C-reactive proteinBaseline and 24, 48, 72h after randomisation
Local and systemic complicationsParticipants will be followed for the duration of hospital stay, an expected average of 7 daysTo be defined according to the 2012 determinant-based classification of acute pancreatitis severity

Countries

New Zealand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026